Table 1.
Characteristics of patients undergoing TET through mid-gut
| Item | Value |
|---|---|
| Total number | 86 |
| Age, mean ± SD, years | 37.1 ± 17.8 |
| Male, n (%) | 43 (50.0) |
| Diseases | |
| Inflammatory bowel disease, n (%) | 36 (41.9) |
| Others, n (%) | 50 (58.1) |
| TET success rate, n (%) | 85 (98.8) |
| Tubing time, mean ± SD, min | 4.2 ± 1.9 |
| Advanced endoscopist, mean ± SD, min | 3.3 ± 0.9 |
| General endoscopist, mean ± SD, min | 5.5 ± 2.4 |
| Aim of TET, n (%) | |
| FMT, n (%) | 65 (75.6) |
| Mini-FMT, n (%) | 27 (31.4) |
| Enteral nutrition, n (%) | 20 (23.3) |
| Satisfaction survey for TET, n (%) | 83 (96.5) |
| Adverse events of patients, n (%) | |
| Procedure-related | |
| Mild pharynx bleeding, n (%) | 1 (1.2) |
| Epistaxis, n (%) | 4 (4.6) |
| Unplanned extubation, n (%) | 2 (2.3) |
| Tube-related | |
| Nausea, n (%) | 1 (1.2) |
| Pharynx discomfort, n (%) | 4 (4.6) |
| Rhinorrhoea, n (%) | 1 (1.2) |
FMT fecal microbiota transplantation, TET transendoscopic enteral tubing